Ectoproteases may also aid in identifying and developing novel strategies for cancer treatment, including the difficult-to-treat triple-negative breast cancer through the inhibition of ADAM17 or MMP9 [295,296]. Here, ADAM17 is linked to triple-negative breast carcinoma.